An explainable transformer model learning from entire treatment timelines for pan-cancer risk profiling across healthcare systems
Keyl, P.; Kiermeyer, N.; Bosserhoff, J.; Lenfers, T.; Niederhauser, T.; Fan, B.; Schnake, T.; Schallenberg, S.; Aubele, F.; Kuss, S.; Idaji, M. J.; Jurmeister, P.; Kim, M.; Bauer, S.; Bechrakis, N.; Forsting, M.; Fuehrer-Sakel, D.; Glas, M.; Gruenwald, V.; Hadaschik, B.; Herrmann, K.; Kasper, S.; Kimmig, R.; Lang, S.; Pretzell, I.; Rassaf, T.; Roesch, A.; Siveke, J. T.; Guberina, M.; Sure, U.; Wichert, M.; Ingrisch, M.; Unger, K.; Behr, J.; Teupser, D.; Stief, C. G.; Mayerle, J.; Harbeck, N.; Tufman, A.; Ricke, J.; Lindner, L. H.; Priglinger, S.; Hoeglinger, G.; Mahner, S.; Canis, M.; Heinzerl
Show abstract
Cancer outcomes vary widely between individual patients, each accumulating an irregular record of treatments, diagnoses, measurements, and complications. Current prognostic models reduce this complexity into a single snapshot, focus on narrow clinical settings, and rarely generalize across hospitals. Here we introduce Chronicle, an explainable transformer that learns from entire patient trajectories, predicts diverse clinical outcomes throughout the disease course while capturing both short- and long-term temporal dependencies. Trained on 53.7 million longitudinal data points from 51,711 patients spanning 67 cancer types, Chronicle operates natively on irregular data without imputation and jointly predicts eight endpoints within a flexible framework adaptable to additional outcomes. Chronicle outperformed cross-sectional models for overall survival prediction (C-index 0.84 vs 0.76-0.79), stratified patients more accurately than established prognostic systems, including TNM stage, and predicted seven adverse event and transfusion endpoints (AUC 0.80-0.92). Applied without retraining to 69,341 patients in Germany, Switzerland, and the United States, Chronicle generalized across healthcare systems and improved further with local fine-tuning. Integrated explainability traced each risk update to patient-specific clinical factors, revealing distinct temporal persistence of prognostic information, with relevance half-lives ranging from weeks for therapies to nearly one year for baseline characteristics. These findings demonstrate that learning from hospital-wide patient trajectories enables interpretable and continuously updated predictions, providing a scalable framework to support individualized treatment decisions.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence 96%
- Clinical interpretation of integrative molecular profiles to guide precision cancer medicine 95%
- UnitedMet harnesses RNA-metabolite covariation to impute metabolite levels in clinical samples 94%
Similar papers in this journal
- Cross-Platform Omics Prediction procedure enables precision medicine in patients with stage-III melanoma 95%
- Federated Target Trial Emulation using Distributed Observational Data for Treatment Effect Estimation 94%
- High-Sensitivity Pan-Cancer AI Assessment of Lymph Node Metastasis via Uncertainty Quantification 94%
Similar papers in this journal
- Pretrained Patient Trajectories for Adverse Drug Event Prediction Using Common Data Model-based Electronic Health Records 94%
- The Interpretable Multimodal Machine Learning (IMML) framework reveals pathological signatures of distal sensorimotor polyneuropathy 93%
- Complex patterns of multimorbidity associated with severe COVID-19 and Long COVID 93%
Similar papers in this journal
- AI-Driven Predictive Biomarker Discovery with Contrastive Learning to Improve Clinical Trial Outcomes 97%
- Single-cell lineage and transcriptome reconstruction of metastatic cancer reveals selection of aggressive hybrid EMT states 94%
- Evolutionary states and trajectories characterized by distinct pathways stratify ovarian high-grade serous carcinoma patients 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.